Table 2.
Susceptibility antibiotic pattern for each Pseudomonas aeruginosa isolate analysed
| |
|
ANTIBIOTICSb |
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strain | Antibiotic patterna | AMK | GEN | TOB | IMP | MEM | CAZ | FEP | CIP | LVX | ATM | TZP | COL | FOS | IMP-EDTA |
| PaC1 |
XDR |
S |
S |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC49 |
MDR |
S |
S |
S |
R |
R |
I |
R |
S |
S |
R |
S |
S |
S |
Neg |
| PaC51 |
non-MDR |
S |
S |
S |
R |
R |
S |
S |
S |
S |
S |
S |
S |
R |
Neg |
| PaC52 |
XDR |
S |
I |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC2 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
I |
R |
S |
R |
Neg |
| PaC3 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
R |
R |
S |
S |
S |
R |
- |
| PaC4 |
non-MDR |
S |
I |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
- |
| PaC5 |
XDR |
S |
S |
S |
R |
R |
R |
R |
S |
I |
R |
R |
S |
R |
Neg |
| PaC7 |
MDR |
S |
S |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
S |
Neg |
| PaC16 |
MDR |
S |
S |
S |
R |
I |
R |
R |
R |
R |
R |
R |
S |
S |
Neg |
| PaC9 |
XDR |
S |
I |
S |
R |
R |
S |
R |
R |
R |
R |
S |
S |
R |
Neg |
| PaC10 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
I |
R |
S |
R |
Neg |
| PaC19 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
S |
R |
Neg |
| PaC32 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
I |
R |
S |
R |
Neg |
| PaC40 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
S |
R |
Neg |
| PaC11 |
XDR |
R |
R |
R |
S |
S |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC24 |
XDR |
R |
R |
R |
S |
S |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC12 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Pos |
| PaC14 |
non-MDR |
S |
I |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC15 |
MDR |
S |
I |
S |
S |
S |
S |
S |
S |
S |
I |
S |
S |
R |
- |
| PaC17 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC18a |
non-MDR |
S |
I |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC18b |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC20 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC21 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC23 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
- |
| PaC25a |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC25b |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC26 |
XDR |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC27 |
non-MDR |
S |
S |
S |
R |
S |
S |
S |
S |
S |
S |
S |
S |
R |
Neg |
| PaC28 |
MDR |
S |
S |
S |
S |
S |
S |
S |
R |
S |
R |
S |
S |
R |
Neg |
| PaC29 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC30 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
S |
- |
| PaC31 |
MDR |
S |
S |
S |
R |
R |
S |
S |
R |
R |
R |
S |
S |
R |
Neg |
| PaC33 |
XDR |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC34 |
MDR |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
S |
S |
Pos |
| PaC35 |
MDR |
I |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
S |
S |
Pos |
| PaC36a |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC36b |
MDR |
S |
R |
R |
R |
R |
S |
S |
R |
R |
S |
R |
S |
R |
Neg |
| PaC37 |
XDR |
S |
R |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC38 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Pos |
| PaC39 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC41 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
- |
| PaC42 |
MDR |
S |
S |
S |
R |
R |
R |
R |
S |
S |
R |
R |
S |
R |
Neg |
| PaC56 |
MDR |
S |
S |
S |
R |
R |
R |
R |
S |
S |
R |
S |
S |
R |
Neg |
| PaC43 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
S |
R |
Pos |
| PaC44 |
non-MDR |
S |
I |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC45 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
Neg |
| PaC46 |
MDR |
S |
S |
S |
R |
R |
I |
S |
S |
R |
S |
S |
S |
S |
Neg |
| PaC47 |
XDR |
S |
R |
R |
R |
R |
R |
R |
R |
R |
S |
R |
S |
R |
Neg |
| PaC48 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC54 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC50 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
Neg |
| PaC53 |
non-MDR |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
R |
- |
| PaC55 |
non-MDR |
S |
S |
S |
R |
R |
I |
S |
S |
S |
S |
S |
S |
S |
Neg |
| PaC57 | non-MDR | S | S | S | S | S | S | S | S | S | S | S | S | R | - |
aThe isolates were classified according to the resistance pattern, as multidrug-resistant (MDR, non-susceptible to ≥1 agent in ≥3 antibiotic categories), extensively drug-resistant (XDR, non-susceptible to ≥1 agent in all but ≤2 antibiotic categories) and non-multidrug resistant (non-MDR).
bAntibiotics tested: Amikacin (AMK), Gentamicin (GEN), Tobramycin (TOB), Imipenem (IMP), Meropenem (MEM), Ceftazidime (CAZ), Cefepime (FEP), Ciprofloxacin (CIP), Levofloxacin (LVX), Aztreonam (ATM), Piperacilin/Tazobactam (TZP), Colistin (COL), Fosfomycin (FOS), Imipenem-EDTA (IMP-EDTA). Results are indicated as S sensitive, I intermediate, R non-susceptibility, Neg negative, Pos positive, - not applicable.